Scholarlink

Objective <p>Tumor-derived exosomes testing can be effective in diagnosing disease and assisting in the treatment of disease. Our study utilizes bibliometric analysis to identify research hotspots related to tumor-derived exosomes, predict emerging research frontiers and development trends, and offer diverse perspectives for advancing research in this field.</p> Methods <p>Search the Web of Science Core Collection for English-language literature published on the field of tumor-derived exosomes from 2015 to 2024. CiteSpace(6.2.R3) software was utilized to visualize the distribution of countries/regions, institutions, authors, co-cited authors, and co-cited journals within the relevant literature. Additionally, co-occurrence, clustering, and emergence analyses were conducted on the co-cited references.</p> Results <p>An analysis of 2523 articles meeting the inclusion criteria revealed a steady increase in the number of publications in this field over the past decade. In terms of countries/regions, institutions, authors, and journals that published articles, the most productive were China, Ministry of Education-China, Theresa L. Whiteside, and <i>CANCER RES</i>, respectively. The most influential were The United States, Harvard University, Theresa L. Whiteside, and <i>CANCER RES</i>, respectively. The mechanisms underlying exosomal PD-L1 and engineered exosomes are currently prominent research foci, warranting meticulous examination by the academic community.</p> Conclusion <p>Within the field of research on tumor-derived exosomes, current investigations appear largely concentrated on the exosome PD-L1 mechanism and engineered exosomes. Possible future research hotspots will focus on the use of engineered exosomes to target tumor cells and as a drug delivery platform for more precise therapeutic targeting.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Visualizing and analyzing global knowledge maps and emerging research trends in tumor-derived exosomes using CiteSpace

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月25日

查看全文
  • Ruijun Guo,
  • Jiajun Xu,
  • Chunxia Li,
  • Chune Mo,
  • Minglin Ou

摘要

Objective

Tumor-derived exosomes testing can be effective in diagnosing disease and assisting in the treatment of disease. Our study utilizes bibliometric analysis to identify research hotspots related to tumor-derived exosomes, predict emerging research frontiers and development trends, and offer diverse perspectives for advancing research in this field.

Methods

Search the Web of Science Core Collection for English-language literature published on the field of tumor-derived exosomes from 2015 to 2024. CiteSpace(6.2.R3) software was utilized to visualize the distribution of countries/regions, institutions, authors, co-cited authors, and co-cited journals within the relevant literature. Additionally, co-occurrence, clustering, and emergence analyses were conducted on the co-cited references.

Results

An analysis of 2523 articles meeting the inclusion criteria revealed a steady increase in the number of publications in this field over the past decade. In terms of countries/regions, institutions, authors, and journals that published articles, the most productive were China, Ministry of Education-China, Theresa L. Whiteside, and CANCER RES, respectively. The most influential were The United States, Harvard University, Theresa L. Whiteside, and CANCER RES, respectively. The mechanisms underlying exosomal PD-L1 and engineered exosomes are currently prominent research foci, warranting meticulous examination by the academic community.

Conclusion

Within the field of research on tumor-derived exosomes, current investigations appear largely concentrated on the exosome PD-L1 mechanism and engineered exosomes. Possible future research hotspots will focus on the use of engineered exosomes to target tumor cells and as a drug delivery platform for more precise therapeutic targeting.